Perimeter Medical Imaging AI (CVE:PINK) Second Quarter 2024 Results

Key Financial Results

• Net loss: US$3.18m (loss narrowed by 35% from 2Q 2023).

• US$0.05 loss per share (improved from US$0.076 loss in 2Q 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Perimeter Medical Imaging AI Revenues and Earnings Beat Expectations

Revenue exceeded analyst estimates by 24%. Earnings per share (EPS) also surpassed analyst estimates by 37%.

Looking ahead, revenue is forecast to grow 61% p.a. on average during the next 3 years, compared to a 8.1% growth forecast for the Medical Equipment industry in North America.

Performance of the market in Canada.

The company's shares are down 16% from a week ago.

Risk Analysis

Be aware that Perimeter Medical Imaging AI is showing 6 warning signs in our investment analysis and 3 of those don't sit too well with us...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.